Abnormal amyloid β(42) expression and increased oxidative stress in plasma of CKD patients with cognitive dysfunction: A small scale case control study comparison with Alzheimer's disease

BACKGROUND: Cognitive dysfunction has been increasingly recognized in chronic kidney disease (CKD) patients. Senile plaques are important pathophysiological characteristic of cognitive dysfunction. The major component of plaques is the amyloid β (Aβ) peptide released from proteolytic cleavage of amy...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinothkumar, G., Kedharnath, C., Krishnakumar, S., Sreedhar, S., Preethikrishnan, K., Dinesh, S., Sundaram, A., Balakrishnan, D., Shivashekar, G., Sureshkumar, Venkataraman, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491400/
https://www.ncbi.nlm.nih.gov/pubmed/28702365
http://dx.doi.org/10.1016/j.bbacli.2017.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491400/
https://www.ncbi.nlm.nih.gov/pubmed/28702365
http://dx.doi.org/10.1016/j.bbacli.2017.06.001

Ejemplares similares